Bladder Cancer
CD8+ TÂ cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy.
January 6, 2023
Association Between Body Mass Index and Outcomes in Patients With Urothelial Carcinoma Treated With Pembrolizumab.
January 6, 2023
Role of Perioperative Immune Checkpoint Inhibitors in Muscle Invasive Bladder Cancer.
January 5, 2023
Urinary biomarkers for bladder cancer diagnosis and NMIBC follow-up: a systematic review.
January 4, 2023
Urinary Analysis of FGFR3 and TERT Gene Mutations Enhances Performance of Cxbladder Tests and Improves Patient Risk Stratification.
January 2, 2023
Could we safely omit a Repeat Transurethral Resection of the Bladder (re-TURB) after Hexaminolevulinate Photodynamic Diagnostics (PDD)-TURB?
December 30, 2022
AB0 blood groups and oncological and functional outcomes in bladder cancer patients treated with radical cystectomy.
December 30, 2022
Radical cystectomy and urinary diversion outcomes in patients with single vs. double renal unit: A 2:1 matched-pair analysis.
December 29, 2022
Natural history of multiple recurrences in intermediate-risk non-muscle invasive bladder cancer: lessons from a prospective cohort.
December 29, 2022
Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer.
December 28, 2022
Female sexual function in bladder cancer: A review of the evidence.
December 28, 2022